State Street Corp Atreca, Inc. Transaction History

State Street Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.13 - $0.38 $286 - $836	-2,200 Reduced 2.4%	89,320 $11,000
Q3 2022 Nov 15, 2022	SELL	$1.59 - $2.74 $2,757 - $4,751	-1,734 Reduced 1.86%	91,520 $144,000
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $720,709 - $1.5 Million	-461,993 Reduced 83.2%	93,254 $167,000
Q1 2022 May 16, 2022	BUY	$1.61 - $5.2 $125,254 - $404,549	77,798 Added 16.29%	555,247 $1.76 Million
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $83,901 - $183,881	-29,234 Reduced 5.77%	477,449 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$4.91 - $9.07 $73,900 - $136,512	15,051 Added 3.06%	506,683 $3.16 Million
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $4.96 Million - $8.76 Million	-634,868 Reduced 56.36%	491,632 $4.19 Million
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $2.11 Million - $3.14 Million	162,579 Added 16.87%	1,126,500 $17.3 Million
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $7.45 Million - $9.77 Million	571,893 Added 145.88%	963,921 $15.6 Million
Q3 2020 Nov 10, 2020	BUY	$12.67 - $23.19 $411,825 - $753,767	32,504 Added 9.04%	392,028 $5.48 Million
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $959,219 - $1.8 Million	76,615 Added 27.08%	359,524 $7.65 Million
Q1 2020 May 11, 2020	BUY	$11.4 - $27.28 $3.23 Million - $7.72 Million	282,909 New	282,909 $4.68 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.